Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S7 pseudogene 10 (RPS7P10) is a **processed pseudogene** on the human genome with high sequence similarity to the functional RPS7 gene, which encodes a component of the 40S small ribosomal subunit[1][3][6]. As a pseudogene, RPS7P10 does not produce a functional protein or participate directly in cellular or disease processes. Like other processed pseudogenes of ribosomal protein genes, RPS7P10 results from ancestral gene duplications and subsequent loss of coding potential; it is typically considered genomically inert and is not a target for therapeutic intervention or drug development[1][3][6].\n\nIf you intended to ask about the active **ribosomal protein S7** (RPS7), that is a functional protein and associated with ribosome assembly, translation, and, when mutated, rare diseases such as Diamond-Blackfan anemia[3][6]. RPS7P10, however, is simply an inactive pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S7 pseudogene 10 (RPS7P10).